Status: Not yet recruiting
Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)
The goal of this prospective phase 2 study is to assess the efficacy and safety of intestinal or multivisceral transplantation for participants with PMP not amenable to other curative-intent treatments. Participants will undergo intestinal/multivisceral transplantation. Participants will be followed for 12 months to assess efficacy and safety.
Participants needed: 20
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Case Comprehensive Cancer CenterUpdated: Jun 5, 2026Locations: 1
Eligibility criteria
Subjects must have histologically confirmed pseudomyxoma peritonei (PMP) [+17]
Subjects with peritoneal carcinomatous originating from an etiology other than P... [+4]